It is difficult to comment on the full impact of the Affordable Care Act (ACA), since it is complex and how each provision will impact each component of health care is still not fully understood. As with any legislation, there are both positive and negative aspects.
Specific to oncology, one of the greatest impacts of the ACA will be the move to a bundled payment for a treatment of a disease. This will refocus the question in multidisciplinary tumor boards from “what is the ideal way to stage, treat, and manage the patient” to “what is the ideal way to stage, treat, and manage the patient within the reimbursement envelope for their disease.” The ultimate impact of these 7 paradigm-changing words remains to be determined.
More on the Supreme Court Decision
| Derek Raghavan | Bruce Minsky | Nora Janjan | Michael Glodé | ||||
| |
Spiraling Costs: Who Will Address the Role of Medicolegal Drivers? | The Move to Bundled Payments Will Be Paradigm-Changing | This Accelerates the Path to a Single-Payer System | Flaws and All, This Is a Start | |||
| James B. Yu | Lawrence Wagman | ||||||
| |
Cancer Will No Longer Be a Financial Death Blow to Many Patients | Impact on Daily Practice Is Completely Unknown | |||||
